Capivasertib – a huge success story for UK science 08 Dec 2022 The latest major breakthrough in cancer is a drug called capivasertib, which has shown ‘remarkable’ results against advanced breast cancer in its first phase III trial. Henry French gives an update Find out more Show/Hide
Our research impact: breast cancer radiotherapy 12 May 2022 To mark our outstanding success in REF2021, Gege Li spoke to two of our researchers here at the ICR who have played central roles in improving the use of radiotherapy in the treatment of breast cancer – transforming the lives of many thousands of patients. Find out more Show/Hide
How decades of clinical trials have transformed breast cancer radiotherapy 25 Oct 2021 After leading numerous practice-changing trials, Professor John Yarnold received a prestigious award at the 2021 ESTRO Congress. For Breast Cancer Awareness Month, Diana Cano looks back at the huge impact he has had in the field of breast cancer radiotherapy. Find out more Show/Hide